MOSCOW (MRC) -- Clariant, a world leader in specialty chemicals, has announced availability of new special-effect colors in the MEVOPUR family of consistent and compliant masterbatches and pre-colored compounds, according to the company's press release.
Several factors combine to increase the importance of using color creatively in the healthcare market, explains Steve Duckworth, Clariant’s Global Head, Healthcare Polymer Solutions. "Diseases such as COPD and diabetes are rapidly increasing," he says, "and self-administered medication, via auto injector or inhaler is becoming the norm. At the same time, U.S. studies indicate only 28% patient-adherence to treatment programs. The cost of wasted medication and follow-on treatment is estimated in the billions of dollars and companies are looking for ways to make their devices more attractive and easier to use, creating standard ‘device platforms’ that can be customized with color and special effects."
When added to plastics, special effect pigments create a singular impression like pearlescence, sparkle or a metallic look. These materials have been used for many years to enhance the look and market appeal of personal care and consumer goods, where less regulatory documentation is required.
Now, however, Clariant has completed the testing to confirm the ingredients of these new special-effect masterbatches and compounded materials conform to medical and pharmaceutical norms. Like all products supplied under the MEVOPUR brand, they are aligned with USP parts 87 and 88 (Class VI devices) and ISO10993. Manufacturing takes place at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia.
As MRC informed previously, in April 2015, Clariant acquired the black pigment preparations portfolio of Lanxess, located at Nagda, Madhya Pradesh. This product line of Lanxess manufactures black pigment preparations used for processing of viscose fibre, which goes in the manufacture of mainly viscose-based apparels, knitwear, towels, bed-linen, etc. With this acquisition, Clariant in India gains additional pigment preparation capacity to cater to a larger, wider customer base.
Clariant in India has local pigment production activities at its Roha (Maharashtra) and Cuddalore (Tamil Nadu) sites. In the year 2014, Clariant invested in the expansion of its Roha pigments facility, thus strengthening its commitment to India.
MRC